%PDF-1.4
%
30 0 obj
<>
endobj
xref
30 94
0000000016 00000 n
0000002273 00000 n
0000002784 00000 n
0000002821 00000 n
0000002866 00000 n
0000003061 00000 n
0000003116 00000 n
0000003266 00000 n
0000003374 00000 n
0000003485 00000 n
0000003605 00000 n
0000003725 00000 n
0000003841 00000 n
0000003957 00000 n
0000004089 00000 n
0000004211 00000 n
0000004400 00000 n
0000004531 00000 n
0000004667 00000 n
0000004788 00000 n
0000004903 00000 n
0000005036 00000 n
0000005156 00000 n
0000005278 00000 n
0000005417 00000 n
0000005575 00000 n
0000005697 00000 n
0000005819 00000 n
0000005979 00000 n
0000006108 00000 n
0000006236 00000 n
0000006358 00000 n
0000006482 00000 n
0000006613 00000 n
0000006737 00000 n
0000006875 00000 n
0000007002 00000 n
0000007144 00000 n
0000007271 00000 n
0000007396 00000 n
0000007513 00000 n
0000007643 00000 n
0000007759 00000 n
0000007885 00000 n
0000008028 00000 n
0000008148 00000 n
0000008293 00000 n
0000008422 00000 n
0000008552 00000 n
0000008672 00000 n
0000008800 00000 n
0000008920 00000 n
0000009044 00000 n
0000009171 00000 n
0000009197 00000 n
0000009385 00000 n
0000010254 00000 n
0000011057 00000 n
0000011923 00000 n
0000012753 00000 n
0000013663 00000 n
0000014567 00000 n
0000015492 00000 n
0000016329 00000 n
0000016362 00000 n
0000016423 00000 n
0000016574 00000 n
0000016722 00000 n
0000016863 00000 n
0000017022 00000 n
0000017626 00000 n
0000018121 00000 n
0000018408 00000 n
0000018490 00000 n
0000046685 00000 n
0000046709 00000 n
0000047357 00000 n
0000047881 00000 n
0000048162 00000 n
0000048243 00000 n
0000087784 00000 n
0000087808 00000 n
0000088132 00000 n
0000088349 00000 n
0000088620 00000 n
0000088698 00000 n
0000091870 00000 n
0000091893 00000 n
0000092275 00000 n
0000092562 00000 n
0000092855 00000 n
0000092936 00000 n
0000102429 00000 n
0000002437 00000 n
trailer<]>>
startxref
0
%%EOF
31 0 obj
<>>>
endobj
123 0 obj
<
>stream
xڵ+Da=\ɔ&Qjd(J1>nwF7!Yؒ[[(6rOS{ M/$$7R%i_w>NlL%тRx=YO4z?Lsƹ+:fIfV`!G,Q2,Xc@MٰM)ʹڣ5u_hֹEC7$1X˛8<"YxgUœO%{/R8
endstream
endobj
32 0 obj
<>
endobj
33 0 obj
[ 34 0 R/XYZ null null null]
endobj
34 0 obj
<>
endobj
35 0 obj
<>
endobj
36 0 obj
<>/Count 46/First 37 0 R/Last 38 0 R/Parent 35 0 R/Title(HIGHLIGHTS OF PRESCRIBING INFORMATION)>>
endobj
37 0 obj
<>/Next 82 0 R/Parent 36 0 R/Title(CONTRAINDICATIONS)>>
endobj
38 0 obj
<>/Parent 36 0 R/Prev 39 0 R/Title(8.6 Renal Impairment)>>
endobj
39 0 obj
<>/Next 38 0 R/Parent 36 0 R/Prev 40 0 R/Title(8.5 Geriatric Use)>>
endobj
40 0 obj
<>/Next 39 0 R/Parent 36 0 R/Prev 41 0 R/Title(8.4 Pediatric Use)>>
endobj
41 0 obj
<>/Next 40 0 R/Parent 36 0 R/Prev 42 0 R/Title(8.2 Lactation)>>
endobj
42 0 obj
<>/Next 41 0 R/Parent 36 0 R/Prev 43 0 R/Title(8.1 Pregnancy)>>
endobj
43 0 obj
<>/Next 42 0 R/Parent 36 0 R/Prev 44 0 R/Title(8 USE IN SPECIFIC POPULATIONS)>>
endobj
44 0 obj
<>/Next 43 0 R/Parent 36 0 R/Prev 45 0 R/Title(7 DRUG INTERACTIONS)>>
endobj
45 0 obj
<>/Next 44 0 R/Parent 36 0 R/Prev 46 0 R/Title(*Sections or subsections omitted from the full prescribing information are not listed.)>>
endobj
46 0 obj
<>/Next 45 0 R/Parent 36 0 R/Prev 47 0 R/Title(6.3 Postmarketing Experience)>>
endobj
47 0 obj
<>/Next 46 0 R/Parent 36 0 R/Prev 48 0 R/Title(17 PATIENT COUNSELING INFORMATION)>>
endobj
48 0 obj
<>/Next 47 0 R/Parent 36 0 R/Prev 49 0 R/Title(6.2 Immunogenicity)>>
endobj
49 0 obj
<>/Next 48 0 R/Parent 36 0 R/Prev 50 0 R/Title(16.2 Storage)>>
endobj
50 0 obj
<>/Next 49 0 R/Parent 36 0 R/Prev 51 0 R/Title(6.1 Clinical Trials Experience)>>
endobj
51 0 obj
<>/Next 50 0 R/Parent 36 0 R/Prev 52 0 R/Title(16.1 How Supplied)>>
endobj
52 0 obj
<>/Next 51 0 R/Parent 36 0 R/Prev 53 0 R/Title(6 ADVERSE REACTIONS)>>
endobj
53 0 obj
<>/Next 52 0 R/Parent 36 0 R/Prev 54 0 R/Title(16 HOW SUPPLIED/STORAGE AND HANDLING)>>
endobj
54 0 obj
<>/Next 53 0 R/Parent 36 0 R/Prev 55 0 R/Title(5.3 Thrombotic Risk with Coronary Artery Brachytherapy)>>
endobj
55 0 obj
<>/Next 54 0 R/Parent 36 0 R/Prev 56 0 R/Title(14 CLINICAL STUDIES)>>
endobj
56 0 obj
<>/Next 55 0 R/Parent 36 0 R/Prev 57 0 R/Title(5.1 Bleeding Events)>>
endobj
57 0 obj
<>/Next 56 0 R/Parent 36 0 R/Prev 58 0 R/Title(13.1 Carcinogenesis, Mutagenesis, Impairment of Fertility)>>
endobj
58 0 obj
<>/Next 57 0 R/Parent 36 0 R/Prev 59 0 R/Title(5 WARNINGS AND PRECAUTIONS)>>
endobj
59 0 obj
<>/Next 58 0 R/Parent 36 0 R/Prev 60 0 R/Title(13 NONCLINICAL TOXICOLOGY)>>
endobj
60 0 obj
<>/Next 59 0 R/Parent 36 0 R/Prev 61 0 R/Title(4 CONTRAINDICATIONS)>>
endobj
61 0 obj
<>/Next 60 0 R/Parent 36 0 R/Prev 62 0 R/Title(12.3 Pharmacokinetics)>>
endobj
62 0 obj
<>/Next 61 0 R/Parent 36 0 R/Prev 63 0 R/Title(3 DOSAGE FORMS AND STRENGTHS)>>
endobj
63 0 obj
<>/Next 62 0 R/Parent 36 0 R/Prev 64 0 R/Title(12.2 Pharmacodynamics)>>
endobj
64 0 obj
<>/Next 63 0 R/Parent 36 0 R/Prev 65 0 R/Title(2.3 Instructions for Administration)>>
endobj
65 0 obj
<>/Next 64 0 R/Parent 36 0 R/Prev 66 0 R/Title(12.1 Mechanism of Action)>>
endobj
66 0 obj
<>/Next 65 0 R/Parent 36 0 R/Prev 67 0 R/Title(2.2 Dose Adjustment in Renal Impairment)>>
endobj
67 0 obj
<>/Next 66 0 R/Parent 36 0 R/Prev 68 0 R/Title(12 CLINICAL PHARMACOLOGY)>>
endobj
68 0 obj
<>/Next 67 0 R/Parent 36 0 R/Prev 69 0 R/Title(2.1 Recommended Dosage)>>
endobj
69 0 obj
<>/Next 68 0 R/Parent 36 0 R/Prev 70 0 R/Title(11 DESCRIPTION)>>
endobj
70 0 obj
<>/Next 69 0 R/Parent 36 0 R/Prev 71 0 R/Title(2 DOSAGE AND ADMINISTRATION)>>
endobj
71 0 obj
<>/Next 70 0 R/Parent 36 0 R/Prev 72 0 R/Title(10 OVERDOSAGE)>>
endobj
72 0 obj
<>/Next 71 0 R/Parent 36 0 R/Prev 73 0 R/Title(1 INDICATIONS AND USAGE)>>
endobj
73 0 obj
<>/Next 72 0 R/Parent 36 0 R/Prev 74 0 R/Title(FULL PRESCRIBING INFORMATION: CONTENTS*)>>
endobj
74 0 obj
<>/Next 73 0 R/Parent 36 0 R/Prev 75 0 R/Title(Revised: 01/2021)>>
endobj
75 0 obj
<>/Next 74 0 R/Parent 36 0 R/Prev 76 0 R/Title(See 17 for PATIENT COUNSELING INFORMATION.)>>
endobj
76 0 obj
<>/Next 75 0 R/Parent 36 0 R/Prev 77 0 R/Title(DOSAGE FORMS AND STRENGTHS)>>
endobj
77 0 obj
<>/Next 76 0 R/Parent 36 0 R/Prev 78 0 R/Title(USE IN SPECIFIC POPULATIONS)>>
endobj
78 0 obj
<>/Next 77 0 R/Parent 36 0 R/Prev 79 0 R/Title(DRUG INTERACTIONS)>>
endobj
79 0 obj
<>/Next 78 0 R/Parent 36 0 R/Prev 80 0 R/Title(DOSAGE AND ADMINISTRATION)>>
endobj
80 0 obj
<>/Next 79 0 R/Parent 36 0 R/Prev 81 0 R/Title(ADVERSE REACTIONS)>>
endobj
81 0 obj
<>/Next 80 0 R/Parent 36 0 R/Prev 82 0 R/Title(INDICATIONS AND USAGE)>>
endobj
82 0 obj
<>/Next 81 0 R/Parent 36 0 R/Prev 37 0 R/Title(WARNINGS AND PRECAUTIONS)>>
endobj
83 0 obj
[ 84 0 R]
endobj
84 0 obj
<>/BS<>/Border[0 0 0]/C[0 0 1]/P 34 0 R/Rect[ 321.75 600.71 404.0299 609.9099]/Subtype/Link/Type/Annot>>
endobj
85 0 obj
<>stream
HWj16mX=h^ҧ^P@:_lB_#HV(nR? 딕ýJ#ᇸӲWQi.8[_)ez\Sܳ=p^҄}C`P2l*_
xM|mdgժ0XK1\tt#H'&[t?q윥8=)3^:(pn0`Lʁ4HΤ#hv9!E_\o7<TWôYwoKH0ݶ+*:S;a7q8Ag6!~M,X$4tk%&],_$(hTbbur,,j4rE^a<[͓1PͲ|(P7X}VsY]ef@S*P)!dEKHg̈f '֙Bp@=RY#˳[N4\lÉK%Xv'}7w5<=};$xe!I0+"oӄ:=Xd'd4V9-Ee*R-vTV7]SWJ)pn=`EG
sl'WWl{p-[KqwmД[7'AN@K6! FwAo:Pju:%
0 U&
endstream
endobj
86 0 obj
<>stream
HWˎ0Qh|ܓ[P94E[CSn!,S9exz&grn͏#X]mwUha
0+lԸ1q-o`\(kܾI5o4~ŹJ[+g˭KFK"IQ6z:&2OX]<0W& $4Q
Vf 1ݳґ_yBjN8f(91HW#n'd~C\Ӛ܈ ?zAٙ3]Sі=H9\s s=jHek:{<O$d,dmA7
fE
c|L{`a"],d%7pִaR!' k*2!Y5KhqTgE1WzqE4ˊJOF}L%v~Bcv9=ṫE7>-jW"OCmCRȁ::SO